Scott Young | VP Corporate Communications & IR |
Mike Clayman | CEO & Co-Founder |
David Arkowitz | CFO |
Daniel Busby | RBC Capital Markets |
Gary Nachman | BMO Capital Markets |
Elliot Wilbur | Raymond James |
Serge Belanger | Needham & Company |
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Third Quarter 2019 Financial Results Conference Call. My name is Dilem, and I'll be your coordinator today. [Operator Instructions] I'll now turn the call over to the company.
Good afternoon. This is Scott Young, Vice President for Corporate Communications and Investor Relations.